Phibro Animal Health | PAHC - Equity Capital And Reserves


Phibro Animal Health reported $361.83M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Align Technology USD 4.23B 83.03M Jun/2026
ANI Pharmaceuticals USD 597.21M 34.91M Jun/2026
Aurora Cannabis CAD 511.83M 24.53M Mar/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Canopy Growth CAD 697.59M 60.58M Mar/2026
Corcept Therapeutics USD 705.78M 67.79M Jun/2026
Eli Lilly USD 33.88B 2.68B Jun/2026
Henry Schein USD 3.16B 109M Jun/2026
Idexx Laboratories USD 1.61B 56.47M Jun/2026
Knight Therapeutics CAD 767.27M 480K Dec/2025
Merck USD 41.93B 3.94B Jun/2026
Nektar Therapeutics USD 576.22M 486.38M Mar/2026
Pacira USD 671.98M 18.08M Jun/2026
Phibro Animal Health USD 361.83M 29.47M Mar/2026
Prestige Brands USD 1.92B 29.2M Jun/2026
Supernus Pharmaceuticals USD 1.03B 45.58M Jun/2026
Zoetis USD 3.15B 85M Jun/2026